JCP Weekly June 19, 2018

Original Research

Predictors of EPS With Aripiprazole in LLD

Augmentation of antidepressants with aripiprazole is effective in treating late-life depression. As an antipsychotic medication, however, aripiprazole potentially leads to extrapyramidal side effects (EPS). Read this article to learn about possible predictors of EPS during aripiprazole augmentation in late-life depression.

DOI: 10.4088/JCP.17m11764 | Posted: 06/19/2018

Original Research

Schizophrenia Relapse After Antipsychotic Discontinuation

High rates of schizophrenia symptom recurrence after antipsychotic treatment discontinuation are are thought to be due to withdrawal-related phenomena rather than illness recurrence. This post hoc analysis examines results from an RCT to determine the true reason for symptom return.

DOI: 10.4088/JCP.17m11874 | Posted: 06/19/2018

See past JCP Weekly